INVESTMENTS
In recent years, Falcon Creek has made several strategic investments in the biotechnology space.
Notable deals include:
HebeCell Corp: Lead investor in this NK cell therapy company based in Boston.
LifeTech Scientific Corp: Co-lead investor in a spinoff deal of a major U.S. company.
Medgro Bio Inc: Lead investor in this plant bioscience company based in Buffalo, New York.
Elixell Therapeutics: Lead investor in this stem cell preclinical biotech company.
Cytek Bioscience: Lead investor in this Nasdaq-listed medical equipment company.
OncoImmune Inc: Acquired by Merck in 2020.
Stellaromics Inc: Co-lead investor with Bayshore Global in this sequencing company in Boston.
Notable deals include:
HebeCell Corp: Lead investor in this NK cell therapy company based in Boston.
LifeTech Scientific Corp: Co-lead investor in a spinoff deal of a major U.S. company.
Medgro Bio Inc: Lead investor in this plant bioscience company based in Buffalo, New York.
Elixell Therapeutics: Lead investor in this stem cell preclinical biotech company.
Cytek Bioscience: Lead investor in this Nasdaq-listed medical equipment company.
OncoImmune Inc: Acquired by Merck in 2020.
Stellaromics Inc: Co-lead investor with Bayshore Global in this sequencing company in Boston.
|
|
|